0001209191-17-041038.txt : 20170620
0001209191-17-041038.hdr.sgml : 20170620
20170620145244
ACCESSION NUMBER: 0001209191-17-041038
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170614
FILED AS OF DATE: 20170620
DATE AS OF CHANGE: 20170620
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Eiger BioPharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001305253
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 361004130
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 350 CAMBRIDGE AVE
STREET 2: SUITE 350
CITY: PALO ALTO
STATE: CA
ZIP: 94306
BUSINESS PHONE: 650-279-9845
MAIL ADDRESS:
STREET 1: 350 CAMBRIDGE AVE
STREET 2: SUITE 350
CITY: PALO ALTO
STATE: CA
ZIP: 94306
FORMER COMPANY:
FORMER CONFORMED NAME: Celladon Corp
DATE OF NAME CHANGE: 20041005
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Apelian David
CENTRAL INDEX KEY: 0001546842
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36183
FILM NUMBER: 17920632
MAIL ADDRESS:
STREET 1: C/O ACHILLION PHARMACEUTICALS, INC
STREET 2: 300 GEORGE STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06511
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2017-06-14
1
0001305253
Eiger BioPharmaceuticals, Inc.
EIGR
0001546842
Apelian David
350 CAMBRIDGE AVE #350
PALO ALTO
CA
94306
1
0
0
0
No securities are beneficially owned.
/s/ David Apelian
2017-06-14